Argent Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Argent Trust Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$560K	Hold	8,994	–	–	0.25%	86
2015 Q2	$756K	Hold	8,994	–	–	0.3%	82
2015 Q1	$676K	Hold	8,994	–	–	0.28%	96
2014 Q4	$559K	Buy	8,994 +63	+0.7%	+$3.59K	0.23%	103
2014 Q3	$464K	Buy	8,931 +456	+5%	+$23.3K	0.18%	109
2014 Q2	$435K	Buy	+8,475	New	+$382K	0.15%	125

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argent Trust Company's XBI Position: Q3 2015 in Review

Argent Trust Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2015 at 8,994 shares worth $560K. The position accounts for 0.25% of the portfolio, ranked #86.

Argent Trust Company first reported a position in XBI in Q2 2014 and has held it in 6 quarters since. The position peaked at $756K in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.

Argent Trust Company held 8,994 shares of State Street SPDR S&P Biotech ETF worth $560K as of Q3 2015.
Argent Trust Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2015.
State Street SPDR S&P Biotech ETF made up 0.25% of Argent Trust Company's portfolio in Q3 2015, its #86 holding.
Argent Trust Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 6 quarters since.
Argent Trust Company's State Street SPDR S&P Biotech ETF position peaked at $756K in Q2 2015.
196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.